We report on a 62-year-old male, who had resection of a large ductal carcinoma in the body and tail of the pancreas. Four months later a metastasis was removed from the abdominal scar, and 14 months later another metastasis was removed from the anterior wall of the stomach. Moreover, he had a left mastectomy followed by radiation therapy for a primary ductal carcinoma and a transurethral resection of the prostate because of benign hyperplasia. A minor focus of primary highly differentiated adenocarcinoma was found in the chips. More than 6 years later, the patient is without any signs of recurrences.
INTRODUCTION
Five-year survival after resection for ductal carcinoma in the body or tail of the pancreas is extremely rare, and only four cases have been reported in the literature.
We report on a patient with proven ductal carcinoma of the pancreas, who is alive more than six years after pancreatic resection. Four months later a solitary metastasis was excised from the abdominal scar. Ten months later the patient had upper abdominal pain, and ultrasonography showed a 6 cm tumor in the anterior wall of the stomach. At laparotomy the tumor was adherent to the left colonic flexure, and resection of the stomach and colon were performed. Three lymph nodes removed during operation and four in the specimen were without metastases.
At twenty-one months a tumor occurred in the left breast, suspected to be a metastasis from the pancreatic cancer, and a mastectomy was performed. At thirty-one months left axillary lymph node dissection was performed because of metastases, and histological revision of the specimen showed ductal breast carcinoma. One of three lymph nodes contained carcinoma and radiation therapy was given. At thirty-nine months, a transurethral resection of the prostate was performed for hyperplasia.
All histological slides were reviewed. The primary tumor in the pancreas was a poorly differentiated ductal adenocarcinoma ( Figure 1 ). Of patients with ductal carcinomas of the pancreatic body and tail, only a few seem to benefit from pancreatic resection, as most patients die within one year.
Only by detailed reporting on long-term survivors, it will be possible to decide if they possess unique characteristics.
